We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




How Stress Increases Cardiovascular Risk

By Biotechdaily staff writers
Posted on 10 Jun 2002
Researchers have found that mental stress contributes to the risk of cardiac disease by causing changes in the endothelial cells of blood vessels that interfere with their ability to dilate. More...
This serves to restrict the flow of blood, a condition that can increase the risk of a heart attack or stroke.

It is well known that grief, anger, shock or other severely stressful events can cause sudden cardiac death. How this happens at the molecular level was not clear. Now a study published in the May 20, 2002, issue of Circulation describes the biochemical effect of mental stress on blood vessels.

The researchers, from University Hospital (Zurich, Switzerland), studied subjects aged 20-31 years old with no known cardiovascular risk factors. Ultrasound was used in five individuals to assess the ability of their blood vessels to dilate both before and 10 minutes after a three-minute mental stress task. Six subjects had dilation measured before and after the task while being infused with a drug called an ETa (endothelin-A) receptor blocker that causes dilation. For comparison, saline was infused in a control group of three people. For the mental stress task, subjects had to respond as quickly as possible to colored lights by pushing a button of the corresponding color. Researchers found a significant decrease in blood-vessel dilation after mental stress. The mental stress test increased average arterial blood pressure from 83-96 millimeters of mercury (mm Hg) and heart rate from 63-81 beats per minute. Flow-mediated dilation was reduced by half, from 8.0 to 4.1.

Administration of the ETa receptor blocker prevented this significant drop in dilation capability (8.6 before vs. 9.4 at 10 minutes after). The investigators believe this response identifies ETa activation as a mechanism responsible for endothelial dysfunction; therefore, blocking ETa receptors may be a novel way to prevent atherosclerosis.

"Endothelial dysfunction induced by mental stress offers a novel and unique link between psychological factors and the cause of atherosclerosis, similar to other risk factors that impair function such as high cholesterol or high blood pressure,” explained Dr. Georg Noll.



Related Links:
University Hospital (Zurich)

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Immunoassay Analyzer
Procise DX
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.